An investigation into the use of an extended lipid panel in the screening of cardiovascular events

Q4 Medicine
M. Shivasekar, T. Jaishankar, V. Vinodhini
{"title":"An investigation into the use of an extended lipid panel in the screening of cardiovascular events","authors":"M. Shivasekar, T. Jaishankar, V. Vinodhini","doi":"10.4103/jms.jms_94_21","DOIUrl":null,"url":null,"abstract":"Introduction: Low-density lipoprotein (LDL) is classified into many subclasses based on its atherogenic propensity, with small dense (sd) LDL being a highly important risk biomarker for early coronary heart disease (CHD). Nonhigh-density lipoprotein cholesterol (non-HDLc) is made up of all atherogenic apolipoprotein B-containing lipoproteins, including low-density lipoprotein cholesterol, very-low-density lipoprotein-C, intermediate-density lipoprotein-C, lipoprotein (a), chylomicrons, and chylomicron remnants. Apolipoproteins, which include apolipoprotein B and apolipoprotein A1, are cholesterol transporters that play a key role in lipid metabolism. Furthermore, Apo-B and Apo-A1 indicate total atherogenic and nonatherogenic particles, respectively. Materials and Methods: This case–control research was done on participants visiting the cardiology and medicine OP in SRM Medical College Hospital and Research Center. The research included 546 people ranging in age from 30 to 55 years. After an overnight fast, blood samples were obtained for the measurement of apolipoprotein-B and apolipoprotein-A1 using the enzyme-linked immunosorbent assay technique. The calculation was used to determine the sd-LDL, non-HDL, and Apo-B/Apo-A1 ratios. Results: When compared to controls, the CHD group had significantly higher levels of sd-LDL, non-HDL, apolipoproteins, and the Apo-B/Apo-A1 ratio. In contrast, the mean level of LDL in CHD was higher and statistically significant (P < 0.001) when compared to normal healthy controls. Conclusion: The study shows that there is a high correlation between sd-LDL, nonHDL-C, apolipoproteins, and their Apo-B/Apo-A1 ratio. When compared to standard lipid indicators, the estimate of all of these parameters appears to be a better marker in predicting the early risk of cardiovascular disease in both diabetic and nondiabetic CHD participants and might be utilized successfully in clinical practice.","PeriodicalId":39636,"journal":{"name":"JMS - Journal of Medical Society","volume":"37 1","pages":"13 - 19"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMS - Journal of Medical Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jms.jms_94_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Low-density lipoprotein (LDL) is classified into many subclasses based on its atherogenic propensity, with small dense (sd) LDL being a highly important risk biomarker for early coronary heart disease (CHD). Nonhigh-density lipoprotein cholesterol (non-HDLc) is made up of all atherogenic apolipoprotein B-containing lipoproteins, including low-density lipoprotein cholesterol, very-low-density lipoprotein-C, intermediate-density lipoprotein-C, lipoprotein (a), chylomicrons, and chylomicron remnants. Apolipoproteins, which include apolipoprotein B and apolipoprotein A1, are cholesterol transporters that play a key role in lipid metabolism. Furthermore, Apo-B and Apo-A1 indicate total atherogenic and nonatherogenic particles, respectively. Materials and Methods: This case–control research was done on participants visiting the cardiology and medicine OP in SRM Medical College Hospital and Research Center. The research included 546 people ranging in age from 30 to 55 years. After an overnight fast, blood samples were obtained for the measurement of apolipoprotein-B and apolipoprotein-A1 using the enzyme-linked immunosorbent assay technique. The calculation was used to determine the sd-LDL, non-HDL, and Apo-B/Apo-A1 ratios. Results: When compared to controls, the CHD group had significantly higher levels of sd-LDL, non-HDL, apolipoproteins, and the Apo-B/Apo-A1 ratio. In contrast, the mean level of LDL in CHD was higher and statistically significant (P < 0.001) when compared to normal healthy controls. Conclusion: The study shows that there is a high correlation between sd-LDL, nonHDL-C, apolipoproteins, and their Apo-B/Apo-A1 ratio. When compared to standard lipid indicators, the estimate of all of these parameters appears to be a better marker in predicting the early risk of cardiovascular disease in both diabetic and nondiabetic CHD participants and might be utilized successfully in clinical practice.
扩展脂质面板在心血管事件筛查中的应用研究
低密度脂蛋白(LDL)根据其致动脉粥样硬化倾向被分为许多亚类,其中小密度(sd) LDL是早期冠心病(CHD)非常重要的风险生物标志物。非高密度脂蛋白胆固醇(non-HDLc)由所有致动脉粥样硬化载脂蛋白b的脂蛋白组成,包括低密度脂蛋白胆固醇、极低密度脂蛋白-c、中密度脂蛋白-c、脂蛋白(a)、乳糜微粒和乳糜微粒残余物。载脂蛋白,包括载脂蛋白B和载脂蛋白A1,是胆固醇转运蛋白,在脂质代谢中起关键作用。此外,Apo-B和Apo-A1分别表示总动脉粥样硬化颗粒和非动脉粥样硬化颗粒。材料与方法:本研究为病例对照研究,研究对象为SRM医学院附属医院及研究中心心内科门诊就诊的患者。这项研究包括546名年龄在30岁到55岁之间的人。禁食一夜后,取血样,采用酶联免疫吸附测定技术测定载脂蛋白b和载脂蛋白a1。计算sd-LDL、non-HDL和Apo-B/Apo-A1比值。结果:与对照组相比,冠心病组sd-LDL、非hdl、载脂蛋白水平和Apo-B/Apo-A1比值显著升高。相比之下,冠心病患者LDL的平均水平高于正常健康对照组,且有统计学意义(P < 0.001)。结论:本研究表明sd-LDL、非hdl - c、载脂蛋白及其Apo-B/Apo-A1比值具有高度相关性。与标准脂质指标相比,所有这些参数的估计值似乎是预测糖尿病和非糖尿病性冠心病参与者心血管疾病早期风险的更好标记,并可能在临床实践中成功应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JMS - Journal of Medical Society
JMS - Journal of Medical Society Medicine-Medicine (all)
CiteScore
0.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信